Literature DB >> 24107410

Consistent global approach on reporting of colistin doses to promote safe and effective use.

Roger L Nation1, Jian Li, Otto Cars, William Couet, Michael N Dudley, Keith S Kaye, Johan W Mouton, David L Paterson, Vincent H Tam, Ursula Theuretzbacher, Brian T Tsuji, John D Turnidge.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24107410     DOI： 10.1093/cid/cit680

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  18 in total

1.  Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.

Authors:  Sandrine Marchand; Salim Bouchene; Michèle de Monte; Laurent Guilleminault; Jérôme Montharu; Maria Cabrera; Nicolas Grégoire; Patrice Gobin; Patrice Diot; William Couet; Laurent Vecellio
Journal:  Pharm Res       Date:  2015-06-04       Impact factor: 4.200

2.  Preliminary method for direct quantification of colistin methanesulfonate by attenuated total reflectance Fourier transform infrared spectroscopy.

Authors:  Krista L Niece; Kevin S Akers
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

3.  The Multidrug-Resistant Gram-negative Superbugs Threat Require Intelligent Use of the Last Weapon.

Authors:  Zakuan Zainy Deris
Journal:  Malays J Med Sci       Date:  2015-09

Review 4.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

5.  Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.

Authors:  Matthieu Boisson; Matthieu Jacobs; Nicolas Grégoire; Patrice Gobin; Sandrine Marchand; William Couet; Olivier Mimoz
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

6.  New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.

Authors:  N Grégoire; O Mimoz; B Mégarbane; E Comets; D Chatelier; S Lasocki; R Gauzit; D Balayn; P Gobin; S Marchand; W Couet
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

7.  Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.

Authors:  Kevin S Akers; Matthew P Rowan; Krista L Niece; Ian J Stewart; Katrin Mende; Jason M Cota; Clinton K Murray; Kevin K Chung
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

Review 8.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

9.  Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.

Authors:  N M Smith; J R Lenhard; K R Boissonneault; C B Landersdorfer; J B Bulitta; P N Holden; A Forrest; R L Nation; J Li; B T Tsuji
Journal:  Clin Microbiol Infect       Date:  2020-02-12       Impact factor: 8.067

Review 10.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.